Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/24/2026 | $56.00 | Buy | Truist |
| 3/5/2026 | $44.00 | Hold → Buy | The Benchmark Company |
| 12/8/2025 | $39.00 | Overweight → Neutral | Analyst |
| 11/3/2025 | $39.00 | Equal Weight → Overweight | Wells Fargo |
| 9/23/2025 | $39.00 | Neutral → Buy | Citigroup |
| 8/20/2025 | $43.00 | Neutral → Buy | UBS |
| 8/18/2025 | $32.00 | Buy → Neutral | Roth Capital |
| 5/13/2025 | $49.00 | Neutral → Outperform | Mizuho |
Truist initiated coverage of Antero Resources with a rating of Buy and set a new price target of $56.00
The Benchmark Company upgraded Antero Resources from Hold to Buy and set a new price target of $44.00
Analyst downgraded Antero Resources from Overweight to Neutral and set a new price target of $39.00
DENVER, April 29, 2026 /PRNewswire/ -- Antero Resources Corporation (NYSE:AR) ("Antero Resources," "Antero," or the "Company") today announced its first quarter 2026 financial and operating results. The relevant consolidated financial statements are included in Antero Resources' Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. Highlights:Net production averaged a company record 3.9 Bcfe/d, an increase of 13% from the year ago periodNatural gas production averaged 2.6 Bcf/d, an increase of 21% from the year ago periodLiquids production averaged 206 MBbl/d, in
DENVER, April 29, 2026 /PRNewswire/ -- Antero Midstream Corporation (NYSE:AM) ("Antero Midstream" or the "Company") today announced its first quarter 2026 financial and operating results. The relevant consolidated financial statements are included in Antero Midstream's Quarterly Report on Form 10-Q for the three months ended March 31, 2026. First Quarter 2026 Highlights:Gathering volumes increased by 14% compared to the prior year quarterNet Income was $118 million, or $0.25 per diluted share, in line with the prior year quarterAdjusted Net Income was $138 million, or $0.29 per
DENVER, April 15, 2026 /PRNewswire/ -- Antero Resources (NYSE:AR) ("Antero" or the "Company") today announced that the Company plans to issue its first quarter 2026 earnings release on Wednesday, April 29, 2026 after the close of trading on the New York Stock Exchange. A conference call is scheduled on Thursday, April 30, 2026 at 9:00 am MT to discuss the financial and operational results. A brief Q&A session for security analysts will immediately follow the discussion of the results. To participate in the call, dial in at 877-407-9079 (U.S.), or 201-493-6746 (International) and
4 - ANTERO RESOURCES Corp (0001433270) (Issuer)
4 - ANTERO RESOURCES Corp (0001433270) (Issuer)
4 - ANTERO RESOURCES Corp (0001433270) (Issuer)
8-K - ANTERO RESOURCES Corp (0001433270) (Filer)
8-K - ANTERO RESOURCES Corp (0001433270) (Filer)
10-Q - ANTERO RESOURCES Corp (0001433270) (Filer)
4/A - ANTERO RESOURCES Corp (0001433270) (Issuer)
4 - ANTERO RESOURCES Corp (0001433270) (Issuer)
TORONTO, May 5, 2023 /CNW/ - Argonaut Gold Inc. (TSX:AR) (the "Company", "Argonaut Gold" or "Argonaut") is pleased to announce the voting results obtained at the Company's Annual General and Special Meeting of Shareholders held earlier today. A total of 521,935,132 shares, representing 62.22% of the Company's issued and outstanding shares, were voted at the meeting. The voting results are as follows: Set the Number of Directors to Seven Votes "For" % For Votes "Against" % Against 493,392,070 99.90 % 506,595 0.10 % Election of Directors Director Votes "For" % For Votes "Withheld" % Withheld James E. Kofman 479,652,658 97.12 % 14,246,007 2.88 % Richard Young 493,254,274 99.87 % 644,391 0.13 %
DENVER, May 5, 2021 /PRNewswire/ -- Antero Resources Corporation (NYSE:AR) ("Antero Resources" or the "Company") today announced that Brenda R. Schroer has been appointed to its Board of Directors (the "Board"), as a Class I director, effective as of April 30, 2021. Ms. Schroer is an independent director under the director independence standards set forth in the rules and regulations of the Securities and Exchange Commission and the applicable listing standards of the New York Stock Exchange. Ms. Schroer's appointment brings the size of the Board to eight directors, seven of whom are independent for service on the Board.
SC 13G/A - ANTERO RESOURCES Corp (0001433270) (Subject)
SC 13G - ANTERO RESOURCES Corp (0001433270) (Subject)
SC 13G - ANTERO RESOURCES Corp (0001433270) (Subject)
DENVER, April 29, 2026 /PRNewswire/ -- Antero Resources Corporation (NYSE:AR) ("Antero Resources," "Antero," or the "Company") today announced its first quarter 2026 financial and operating results. The relevant consolidated financial statements are included in Antero Resources' Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. Highlights:Net production averaged a company record 3.9 Bcfe/d, an increase of 13% from the year ago periodNatural gas production averaged 2.6 Bcf/d, an increase of 21% from the year ago periodLiquids production averaged 206 MBbl/d, in
DENVER, April 29, 2026 /PRNewswire/ -- Antero Midstream Corporation (NYSE:AM) ("Antero Midstream" or the "Company") today announced its first quarter 2026 financial and operating results. The relevant consolidated financial statements are included in Antero Midstream's Quarterly Report on Form 10-Q for the three months ended March 31, 2026. First Quarter 2026 Highlights:Gathering volumes increased by 14% compared to the prior year quarterNet Income was $118 million, or $0.25 per diluted share, in line with the prior year quarterAdjusted Net Income was $138 million, or $0.29 per
DENVER, April 15, 2026 /PRNewswire/ -- Antero Resources (NYSE:AR) ("Antero" or the "Company") today announced that the Company plans to issue its first quarter 2026 earnings release on Wednesday, April 29, 2026 after the close of trading on the New York Stock Exchange. A conference call is scheduled on Thursday, April 30, 2026 at 9:00 am MT to discuss the financial and operational results. A brief Q&A session for security analysts will immediately follow the discussion of the results. To participate in the call, dial in at 877-407-9079 (U.S.), or 201-493-6746 (International) and